The purchase is contingent upon approval of the vaccine formulated for the XBB. 1. 5 Omicron subvariant of the virus.
Japan’s Ministry of Health announced on Friday that it had agreed to procure 1. 4 million doses of Daiichi Sankyo’s updated COVID-19 vaccine.
The purchase is contingent upon approval of the vaccine formulated for the XBB. 1. 5 Omicron subvariant of the virus.
An earlier edition of the mRNA-based vaccine was approved in August as a booster, making it Japan’s first coronavirus vaccine.
During the pandemic, Japan has relied heavily on imports of mRNA-like vaccines developed through U. S. drugmakers Pfizer and Moderna. (Reporting via Rocky Swift; editing by Leslie Adler)
Disclaimer: The content of this article is distributed or provided on this online page through a third-party vendor. We are not guilty of and not responsible for those third-party online media sites, entities, applications, or publishers. The text of the framework is provided on an “as is” and “as available” basis and has not been modified in any way. Neither we nor our affiliates guarantee the accuracy or endorse the insights or reviews expressed in this article. Read our full disclaimer policy here.
Get exclusive financial information and content you can trust, delivered to your inbox.